Lifeboat Foundation

The AHA names the top 10 heart disease and stroke research advances of 2017, including new drugs, guidelines, research, and a gene therapy.

New targeted cancer therapies have emerged to fight tumors, and scientists have much more in the pipeline.

Summary: New targeted cancer therapies have been highlighted this month as emerging technologies to fight tumors, and scientists have much more in the pipeline. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]

Targeted cancer therapies – the most famous of which are immunotherapies such as CAR T-cell therapy – are the current focus of excitement in cancer treatment. New therapies and developments in the immunotherapy field prompted the National Cancer Institute (NCI) to update their guidance on targeted cancer therapies a little over a week ago. As the NCI says.

Continue reading “Breakthroughs in Targeted Cancer Therapies to Fight Tumors” »

Summary: Cancer immunotherapy treatments and other approaches to cure nearly all cancers within 8 years says Dr. Gilliland, a prominent cancer research head. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]

Gary Gilliland, M.D., Ph.D. is the President and Director, Fred Hutchinson Cancer Research Center and in an opinion piece published at the beginning of this month, writes.

“I’ve gone on record to say that by 2025, cancer researchers will have developed curative therapeutic approaches for most if not all cancers.”

Continue reading “Breakthrough cancer immunotherapy treatments to be ‘curative’ by 2025 says prominent research head” »

Team paves the way for cancer immunotherapy demonstrating a novel technique that attacked tumors and inhibited cancers from spreading.

Summary: Team paves the way for cancer immunotherapy with a novel technique that attacked tumors and inhibited cancers from spreading. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]

While cancer immunotherapy is a powerful treatment for some types of tumors, up until now, it hasn’t worked well on colon cancer.

Continue reading “Team paves the way for immunotherapy to treat aggressive colon tumors” »

Scientists have designed a test they believe is the first of its kind. Using blood and urine samples, the test correctly identified autism in children.

The new approach could one day allow people to screen themselves for the risks that could lead to heart disease.

Sanming, a city of about 2.5m people in eastern China’s Fujian province, has shown one way out of the conundrum — switching from premium drugs made by multinationals to cheaper local generics and cracking down on doctors taking kickbacks from distributors.

Cheaper drugs cut burden on Sanming budget, but locals grumble over quality of care.

Longevity become hottest object for investments;

Startup founded 5 moths ago just raised $250 million.

The start-up, which launched in September and is headquartered in Warren, N.J., announced Thursday it has raised $250 million in venture capital from global biopharmaceutical company Celgene, biotechnology company United Therapeutics Corporation, biopharmaceutical company Sorrento Therapeutics, DNA sequencing and machine learning company Human Longevity, Inc.

Continue reading “Will 100 be the new 60? Stem cell start-up that raised $250 million could extend lifespan” »

Advance brings us closer to growing transplant organs inside animals or being able to genetically tailor compatible organs, say researchers.

Nicola Davis in Austin.